R Scott McClelland
Overview
Explore the profile of R Scott McClelland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
215
Citations
4891
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benki-Nugent S, Were F, Riederer A, Gatari M, Karr C, Seto E, et al.
BMJ Paediatr Open
. 2025 Feb;
9(1).
PMID: 39922600
Introduction: Air pollution is linked with poor neurodevelopment in high-income countries. Comparable data are scant for low-income countries, where exposures are higher. Longitudinal pregnancy cohort studies are optimal for individual...
2.
Sabo M, Mustafa S, Saha A, Oyaro B, Fiedler T, Krueger M, et al.
J Infect Dis
. 2025 Jan;
PMID: 39874304
Background: The association between bacterial vaginosis (BV) and increased HIV acquisition risk may be related to concentrations of HIV-susceptible immune cells in the cervix. Methods: Participants (31 with BV and...
3.
Tolstrup D, Roberts S, Deya R, Wanje G, Shafi J, James J, et al.
Drug Alcohol Depend Rep
. 2025 Jan;
14:100315.
PMID: 39867466
Aim: Unhealthy alcohol use is often correlated with experiences of intimate partner violence (IPV). We investigated how different types of IPV (sexual, physical, emotional, and financial) were associated with unhealthy...
4.
Alves K, Kotloff K, McClelland R, Kouassi A, Plested J, Kalkeri R, et al.
Lancet Infect Dis
. 2025 Jan;
PMID: 39824198
Background: Authorities globally recommended a monovalent omicron XBB.1.5-based COVID-19 vaccine for the 2023-24 season. The Novavax COVID-19 vaccine, NVX-CoV2601, contains XBB.1.5 recombinant spike protein, based on an authorised prototype vaccine...
5.
Kwendakwema C, Sabo M, Roberts S, Masese L, McClelland R, Shafi J, et al.
Sex Transm Dis
. 2024 Sep;
52(1):29-36.
PMID: 39235112
Background: Sexual violence (SV) increases human immunodeficiency virus (HIV) susceptibility in a sustained manner. This study evaluated genital cytokines and colposcopy findings in women reporting both recent and more remote...
6.
Jones H, Anderson R, Cust H, McClelland R, Richardson B, Thirumurthy H, et al.
Lancet Glob Health
. 2024 Jul;
12(8):e1244-e1260.
PMID: 39030057
Background: Women who engage in sex work in sub-Saharan Africa have a high risk of acquiring HIV infection. HIV incidence has declined among all women in sub-Saharan Africa, but trends...
7.
McClelland R, Lokken E, Kinuthia J, Srinivasan S, Richardson B, Jaoko W, et al.
Paediatr Perinat Epidemiol
. 2024 Jul;
38(7):599-611.
PMID: 38949435
Background: Studies evaluating the association between the vaginal microbiota and miscarriage have produced variable results. Objective: This study evaluated the association between periconceptual and first-trimester vaginal microbiota and women's risk...
8.
Babu T, Shen X, McClelland R, Wang Z, Selke S, Wilkens C, et al.
Open Forum Infect Dis
. 2024 Feb;
11(2):ofad673.
PMID: 38379566
We evaluated the immunologic response to a novel vaccine regimen that included 2 doses of NVX-CoV2373 (Novavax) followed by 1 dose of BNT162b2 (Pfizer-BioNTech) monovalent booster vaccine. A durable neutralizing...
9.
Stewart J, Oware K, Donnell D, Violette L, Odoyo J, Soge O, et al.
N Engl J Med
. 2023 Dec;
389(25):2331-2340.
PMID: 38118022
Background: Doxycycline postexposure prophylaxis (PEP) has been shown to prevent sexually transmitted infections (STIs) among cisgender men and transgender women, but data from trials involving cisgender women are lacking. Methods:...
10.
Barnabas R, Brown E, Onono M, Bukusi E, Njoroge B, Winer R, et al.
Nat Med
. 2023 Dec;
29(12):3224-3232.
PMID: 38049621
Cervical cancer burden is high where prophylactic vaccination and screening coverage are low. We demonstrated in a multicenter randomized, double-blind, controlled trial that single-dose human papillomavirus (HPV) vaccination had high...